Fundraising Fox
TriAgenics
Redmond, US · Delaware corporation · 1 known investors
Find your way into TriAgenics
Sign up to see every warm intro you have to TriAgenics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the TriAgenics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
TriAgenics develops Zero3 TBA (Tooth Bud Ablation), a minimally invasive one-minute dental procedure designed to prevent wisdom teeth from forming by warming the developing tooth buds. The medical device technology is in live animal trials as an alternative to future wisdom tooth extraction.
Founders & leadership
Board
JJ
John Joseph ChopackBoard director
JM
Jeffrey Miles JacobsBoard director
GS
George ShahinBoard director
DP
David Paul WastonBoard director
JC
John Chopack, Jr.Board director
Investors · 1
Galen PartnersreportedStamford
How we know: a partner's Signal profile · Not right? Tell us
Funding
SEC filings, press & company announcements$3.8M disclosed across 3 of 4 rounds · 2018–2025
- Undisclosed amountSeries A-3Jan 2025Source ↗
▶$500KraisedApr 2025 · 1 investors · Other Health CareRule 506(b)
▶$500KraisedApr 2025 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John Joseph ChopackDirector
- David Scott ThrowerExecutive Officer, Director
- Jeffrey Miles JacobsDirector
- George ShahinDirector
- David Paul WastonDirector
- Leigh ColbyExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $500K
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.9MraisedSep 2021 · 27 investors · Other Health Care
▶$1.9MraisedSep 2021 · 27 investors · Other Health Care
Officers, directors & promoters on the filing
- George ShahinDirector
- David ThrowerDirector
- John Chopack, Jr.Director
- David WatsonExecutive Officer, Director
- Leigh ColbyExecutive Officer, Director, Promoter
- Walter DiersExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $1.9M
- Minimum investment
- $87.5K
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 04
▶$1.4MraisedMar 2018 · 1 investors · Other Health CareRule 506(b)
▶$1.4MraisedMar 2018 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Leigh ColbyExecutive Officer, Director, Promoter
- Mike DiersPromoter
- Offering amount
- $1.5M
- Amount sold
- $1.4M
- Minimum investment
- $1.3M
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as TriAgenics.
In the news
Frequently asked questions
- What does TriAgenics do?
- TriAgenics develops Zero3 TBA (Tooth Bud Ablation), a minimally invasive one-minute dental procedure designed to prevent wisdom teeth from forming by warming the developing tooth buds. The medical device technology is in live animal trials as an alternative to future wisdom tooth extraction.
- Who founded TriAgenics?
- TriAgenics was founded by Leigh Colby.
- Who are TriAgenics's investors?
- TriAgenics's investors include Galen Partners.
- How much funding has TriAgenics raised?
- TriAgenics has disclosed $3.8M raised across 3 of its 4 known rounds.
- Where is TriAgenics headquartered?
- TriAgenics is headquartered in Redmond, US.